Evidence map›Paper›PMID 33967350›Full record

ReviewProgress in polymer science2021

Future antiviral polymers by plasma processing.

Chuanlong Ma, Anton Nikiforov, Nathalie De Geyter, Xiaofeng Dai, Rino Morent, Kostya Ken Ostrikov

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Progress in polymer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Beyond Bactericidal: Plasma Surface Engineering to Defeat Food Matrix-Conditioning Layers.Comprehensive reviews in food science and food safety · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuanlong MaResearch Unit Plasma Technology (RUPT), Department of Applied Physics, Ghent University, Sint-Pietersnieuwstraat 41, B4, 9000 Ghent, Belgium.
Anton NikiforovResearch Unit Plasma Technology (RUPT), Department of Applied Physics, Ghent University, Sint-Pietersnieuwstraat 41, B4, 9000 Ghent, Belgium.
Nathalie De GeyterResearch Unit Plasma Technology (RUPT), Department of Applied Physics, Ghent University, Sint-Pietersnieuwstraat 41, B4, 9000 Ghent, Belgium.
Xiaofeng DaiAffiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Rino MorentResearch Unit Plasma Technology (RUPT), Department of Applied Physics, Ghent University, Sint-Pietersnieuwstraat 41, B4, 9000 Ghent, Belgium.
Kostya Ken OstrikovSchool of Chemistry and Physics and QUT Centre for Materials Science, Queensland University of Technology (QUT), 4000 Brisbane, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is largely threatening global public health, social stability, and economy. Efforts of the scientific community are turning to this global crisis and should present future preventative measures. With recent trends in polymer science that use plasma to activate and enhance the functionalities of polymer surfaces by surface etching, surface grafting, coating and activation combined with recent advances in understanding polymer-virus interactions at the nanoscale, it is promising to employ advanced plasma processing for smart antiviral applications. This trend article highlights the innovative and emerging directions and approaches in plasma-based surface engineering to create antiviral polymers. After introducing the unique features of plasma processing of polymers, novel plasma strategies that can be applied to engineer polymers with antiviral properties are presented and critically evaluated. The challenges and future perspectives of exploiting the unique plasma-specific effects to engineer smart polymers with virus-capture, virus-detection, virus-repelling, and/or virus-inactivation functionalities for biomedical applications are analysed and discussed.

Indexed as

ACE2, angiotensin-converting enzyme 2Antiviral polymersBSA, bovine serum albuminCF4, tetrafluoromethaneCOVID-19, coronavirus disease 2019DC, direct currentH2, hydrogenHBV, hepatitis B virusHMDSO, hexamethyldisiloxaneIPNpp, plasma polymerized isopentyl nitriteMERS-CoV, middle east respiratory syndromeMW, microwaveNO, nitric oxidePC, polycarbonatePDMS, polydimethylsiloxanePECVD, plasma-enhanced chemical vapour depositionPEG, polyethene glycolPET, polyethene terephthalatePFM, pentafluorophenyl methacrylateplasma processingPPE, personal protective equipmentPP, polypropylenePS, polystyrenePTFE, polytetrafluoroethylenePVC, polyvinyl chlorideREF, referenceRF, radio frequencyRONS, reactive oxygen and nitrogen speciesRSV, respiratory syncytial virusRT-PCR, reverse transcription-polymerase chain reactionRV, rhinovirusSARS-CoV-2, severe acute respiratory syndrome coronavirus 2SEM, scanning electron microscopysurface modificationTEOS-O2, tetraethyl orthosilicate and oxygenUV, ultravioletWCA, water contact angleΔD, the variation of the dissipationΔf, the frequency shift

Identifiers

PMID33967350
PMCPMC8085113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.